
In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells
Keywords: EGFR, epidermal growth factor receptor; VEGF, vascular endothelial cell growth factor; CDK, cyclin-dependent kinase; CDKI, cyclin-dependant kinase inhibitorPancreatic cancer; Silibinin; Cell cycle; Apoptosis; Angiogenesis